Epivir
Product Images NDC 21695-367

4 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Epivir (NDC 21695-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamivudine Structural Formula (166abd26 675e 4832 9d18 0567f2a9d4e4 01)

Lamivudine Structural Formula (166abd26 675e 4832 9d18 0567f2a9d4e4 01)
Chemical structure of the active ingredient in EPIVIR, showing a nucleoside analog with a pyrimidine base and a thiolane sugar moiety, including nitrogen, oxygen, and sulfur atoms.*
FDA Label Image

Figure 1. Systemic Clearance (l/hr•kg) Of Lamivudine In Relation To Age (166abd26 675e 4832 9d18 0567f2a9d4e4 02)

Figure 1. Systemic Clearance (l/hr•kg) Of Lamivudine In Relation To Age (166abd26 675e 4832 9d18 0567f2a9d4e4 02)
A line graph depicting the relationship between age (years) on the x-axis and systemic clearance on the y-axis. The graph shows a decreasing trend of systemic clearance as age increases from 0 to 60 years.*
FDA Label Image

Figure 2. Virologic Response Through Week 48, Epv20001ab (intent-to-treat) (166abd26 675e 4832 9d18 0567f2a9d4e4 03)

Figure 2. Virologic Response Through Week 48, Epv20001ab (intent-to-treat) (166abd26 675e 4832 9d18 0567f2a9d4e4 03)
A line graph comparing the proportions of patients with HIV-1 RNA fewer than 400 copies/mL over 48 weeks of treatment with EPIVIR at two dosing regimens: 150 mg twice daily and 300 mg once daily. The x-axis represents treatment time in weeks, and the y-axis shows the proportion of patients. Both regimens show an initial increase in response, peaking around weeks 12 to 20, followed by a gradual decline through week 48.*
FDA Label Image

Epivir 150mg (166abd26 675e 4832 9d18 0567f2a9d4e4 04)

Epivir 150mg (166abd26 675e 4832 9d18 0567f2a9d4e4 04)
Label for EPIVIR 150mg tablets by Rebel Distributors Corp showing 60 scored tablets per bottle. The label includes the Physician Partner branding, NDC 21695-367-06, and storage instructions to keep at controlled room temperature 15-30°C (59-86°F). The label states RX Only and provides a product ID PE036706.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.